UMIN-CTR Clinical Trial

Unique ID issued by UMIN UMIN000045633
Receipt number R000052094
Scientific Title Research on newborn screening for treatable neonatal and childhood diseases
Date of disclosure of the study information 2022/01/01
Last modified on 2022/04/01 10:02:46

* This page includes information on clinical trials registered in UMIN clinical trial registed system.
* We don't aim to advertise certain products or treatments


Basic information

Public title

Research on newborn screening for treatable neonatal and childhood diseases

Acronym

Research on expanded newborn screening

Scientific Title

Research on newborn screening for treatable neonatal and childhood diseases

Scientific Title:Acronym

Research on expanded newborn screening

Region

Japan


Condition

Condition

primary immunodeficiency, spinal muscular atrophy

Classification by specialty

Obstetrics and Gynecology Pediatrics

Classification by malignancy

Others

Genomic information

NO


Objectives

Narrative objectives1

We aim for early diagnosis and treatment by performing newborn screening for primary immunodeficiency and spinal muscular atrophy using dried blood spots.

Basic objectives2

Efficacy

Basic objectives -Others


Trial characteristics_1


Trial characteristics_2


Developmental phase



Assessment

Primary outcomes

establishment of implementation system (1 year from the start)

Key secondary outcomes

evaluation of efficacy (epidemiological survey in 10 years)


Base

Study type

Interventional


Study design

Basic design

Single arm

Randomization

Non-randomized

Randomization unit


Blinding

Open -no one is blinded

Control

Uncontrolled

Stratification


Dynamic allocation


Institution consideration


Blocking


Concealment



Intervention

No. of arms

1

Purpose of intervention

Diagnosis

Type of intervention

Other

Interventions/Control_1

screening for primary immunodeficiency and spinal muscular atrophy

Interventions/Control_2


Interventions/Control_3


Interventions/Control_4


Interventions/Control_5


Interventions/Control_6


Interventions/Control_7


Interventions/Control_8


Interventions/Control_9


Interventions/Control_10



Eligibility

Age-lower limit


Not applicable

Age-upper limit

1 months-old >=

Gender

Male and Female

Key inclusion criteria

newborns undergoing current newborn screening

Key exclusion criteria

consent not available

Target sample size

5000


Research contact person

Name of lead principal investigator

1st name Kohsuke
Middle name
Last name Imai

Organization

Tokyo Medical and Dental University

Division name

Pediatrics

Zip code

113-8519

Address

1-5-45, Yushima, Bunkyo, Tokyo

TEL

0338136111

Email

kimai.ped@tmd.ac.jp


Public contact

Name of contact person

1st name Tomoko
Middle name
Last name Mizuno

Organization

Tokyo Medical and Dental University

Division name

Pediatrics

Zip code

1138519

Address

1-5-45, Yushima, Bunkyo, Tokyo

TEL

0338136111

Homepage URL


Email

tmizuno.ped@tmd.ac.jp


Sponsor or person

Institute

Tokyo Medical and Dental University

Institute

Department

Personal name



Funding Source

Organization

AMED

Organization

Division

Category of Funding Organization

Japanese Governmental office

Nationality of Funding Organization



Other related organizations

Co-sponsor


Name of secondary funder(s)



IRB Contact (For public release)

Organization

The department of general affairs, Tokyo Medical and Dental University

Address

1-5-45, Yushima, Bunkyo, Tokyo

Tel

03-5803-5096

Email

syomu1.adm@tmd.ac.jp


Secondary IDs

Secondary IDs

NO

Study ID_1


Org. issuing International ID_1


Study ID_2


Org. issuing International ID_2


IND to MHLW



Institutions

Institutions



Other administrative information

Date of disclosure of the study information

2022 Year 01 Month 01 Day


Related information

URL releasing protocol


Publication of results

Unpublished


Result

URL related to results and publications


Number of participants that the trial has enrolled

0

Results


Results date posted


Results Delayed


Results Delay Reason


Date of the first journal publication of results


Baseline Characteristics


Participant flow


Adverse events


Outcome measures


Plan to share IPD


IPD sharing Plan description



Progress

Recruitment status

Terminated

Date of protocol fixation

2021 Year 09 Month 01 Day

Date of IRB

2021 Year 11 Month 05 Day

Anticipated trial start date

2022 Year 01 Month 01 Day

Last follow-up date

2032 Year 03 Month 31 Day

Date of closure to data entry


Date trial data considered complete


Date analysis concluded



Other

Other related information



Management information

Registered date

2021 Year 10 Month 01 Day

Last modified on

2022 Year 04 Month 01 Day



Link to view the page

Value
https://center6.umin.ac.jp/cgi-open-bin/ctr_e/ctr_view.cgi?recptno=R000052094